Enduring Material

• Advance PCP understanding of psoriasis

Psoriasis for Primary Care Providers, Part 2

• David Rosmarin, MD

• The National Psoriasis Foundation designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The National Psoriasis Foundation designates this enduring material for a maximum of 0.25 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

In the second of this 2- part series, Dr. David Rosmarin, M.D., MAS, assistant professor at Tufts University School of Medicine, continues to share insights into psoriasis for primary care providers.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.

NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.

David Rosmarin, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• AbbVie, Abcuro, AltruBio, Arena, Boehringer-Ingelheim, Bristol Meyers Squibb, Celgene, Concert, CSL Behring, Dermavant, Dermira, Incyte, Janssen, Kyowa Kirin, Lilly, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharmaceuticals, UCB, VielaBio - Consulting - Relationship Has Not Ended
• AbbVie, Amgen, Bristol Meyers Squibb, Celgene, Dermira, Galderma, Incyte, Janssen, Lilly, Merck, Novartis, Pfizer, and Regeneron Pharmaceuticals Inc - Contracted Research - Relationship Has Not Ended
• AbbVie, Amgen, Celgene, Incyte, Janssen, Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi. - Speaking - Relationship Has Not Ended

Any financial relationship that was found to be relevant has been mitigated.

Support for this activity is gratefully acknowledged from Amgen. Support for this activity is gratefully acknowledged from Novartis. Support for this activity is gratefully acknowledged from Pfizer. Support for this activity is gratefully acknowledged from UCB.

• The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

0 %

100 %

11/2/2022